Press "Enter" to skip to content

New patent expiration for APIL drug ACTONEL

0
Listen to this article
Voiced by Amazon Polly
Copyright © DrugPatentWatch. Originally published at New patent expiration for APIL drug ACTONEL

Annual Drug Patent Expirations for ACTONEL
Annual Drug Patent Expirations for ACTONEL

Actonel is a drug marketed by Apil and Warner Chilcott and is included in two NDAs. It is available from four suppliers. There are seven patents protecting this drug and four Paragraph IV challenges.

ACTONEL drug price trends.

Drug patent litigation for ACTONEL.

The generic ingredient in ACTONEL is calcium carbonate; risedronate sodium. Four suppliers are listed for this compound. Additional details are available on the calcium carbonate; risedronate sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for APIL drug ACTONEL
Do NOT follow this link or you will be banned from the site!